Jardiance 25 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26F5QMJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $76,045
Award facts
- Contract value 100% obligated
- $76,045.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $76,045.40. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement with an ultimate completion date of November 13, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026, which authorizes the company to supply a wide range of pharmaceuticals and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated consistent capability in delivering pharmaceuticals to the Defense Logistics Agency through open competition. The company's federal contract portfolio encompasses diabetes medications, neurological treatments, pain management pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains. As a child contract under the DLA's comprehensive pharmaceutical prime vendor program, this Jardiance delivery order supports the Defense Health Agency and broader military healthcare systems. The DLA is planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V regional contracts with multiple awards anticipated, positioning AmerisourceBergen alongside other qualified contractors to continue serving federal healthcare procurement needs.
Quick answers
Who was awarded contract SPE2DR26F5QMJ?
SPE2DR26F5QMJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26F5QMJ worth?
The government has obligated $76,045 on SPE2DR26F5QMJ.
Is contract SPE2DR26F5QMJ an order under another contract?
Yes. SPE2DR26F5QMJ is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5QMJ competed?
The extent of competition for SPE2DR26F5QMJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award